Sialic acid-modified doxorubicin liposomes target tumor-related immune cells to relieve multiple inhibitions of CD8 <sup>+</sup> T cells-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Sialic acid-modified doxorubicin liposomes target tumor-related immune cells to relieve multiple inhibitions of CD8 ⁺ T cells

Published:2024-01-09 Issue:3 Volume:34 Page:464-474
ISSN:0898-2104
Container-title:Journal of Liposome Research
language:en
Short-container-title:Journal of Liposome Research

Author:

Du Zhouchunxiao¹,Sui Dezhi¹,Xin Dongzhe¹,Tang Xueying¹,Li Mingze¹,Liu Xinrong¹,Deng Yihui¹,Song Yanzhi¹

Affiliation:

1. College of Pharmacy, Shenyang Pharmaceutical University, Shenyang, China

Funder

National Natural Science Foundation of China

Career Development Plan for Young and Middle-aged Teachers of Shenyang Pharmaceutical University

Shenyang Pharmaceutical University Innovation and Entrepreneurship Training Program

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/08982104.2023.2298901

Reference46 articles.

1. Nanomaterials for T-cell cancer immunotherapy

2. Cytotoxic CD8+ T cells in cancer and cancer immunotherapy

3. Revisiting the role of CD4+ T cells in cancer immunotherapy—new insights into old paradigms

4. Complementing the Cancer-Immunity Cycle

5. Regulatory T cell targeting in cancer: Emerging strategies in immunotherapy

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP